# ![@booooogy01 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::908043474884325376.png) @booooogy01 Pharma 8k's

Pharma 8k's posts on X about stocks, data, nasdaq, sec the most. They currently have [--] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::908043474884325376/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::908043474884325376/c:line/m:interactions.svg)

- [--] Week [-----] +133%
- [--] Month [------] -3.90%

### Mentions: [--] [#](/creator/twitter::908043474884325376/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::908043474884325376/c:line/m:posts_active.svg)

- [--] Month [--] -33%

### Followers: [--] [#](/creator/twitter::908043474884325376/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::908043474884325376/c:line/m:followers.svg)

- [--] Week [--] +16%
- [--] Month [--] +70%

### CreatorRank: [---------] [#](/creator/twitter::908043474884325376/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::908043474884325376/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [exchanges](/list/exchanges)  [cryptocurrencies](/list/cryptocurrencies)  [countries](/list/countries)  [automotive brands](/list/automotive-brands) 

**Social topic influence**
[stocks](/topic/stocks), [data](/topic/data), [nasdaq](/topic/nasdaq) #1632, [sec](/topic/sec), [pharma](/topic/pharma), [events](/topic/events), [acquisition](/topic/acquisition), [8k](/topic/8k), [bullish](/topic/bullish), [announces](/topic/announces)

**Top accounts mentioned or mentioned by**
[@czarus7777](/creator/undefined)

**Top assets mentioned**
[IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Mist (MIST)](/topic/$mist) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Anebulo Pharmaceuticals, Inc.  (ANEB)](/topic/$aneb) [Century Therapeutics, Inc. (IPSC)](/topic/$ipsc) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Climb Bio, Inc (CLYM)](/topic/$clym) [Neumora Therapeutics, Inc. (NMRA)](/topic/$nmra) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Turn Therapeutics, Inc. (TTRX)](/topic/$ttrx) [ADiTx Therapeutics, Inc. (ADTX)](/topic/$adtx) [Immunovant, Inc. Common Stock (IMVT)](/topic/$imvt) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [CheckDot (CDT)](/topic/$cdt) [BioAtla, Inc. (BCAB)](/topic/$bcab) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Novavax Inc (NVAX)](/topic/$nvax) [Kymera Therapeutics, Inc. (KYMR)](/topic/$kymr) [Prelude Therapeutics Inc. (PRLD)](/topic/$prld) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Amphastar Pharmaceuticals, Inc. (AMPH)](/topic/$amph) [AbbVie Inc (ABBV)](/topic/$abbv) [Tenaya Therapeutics, Inc.  (TNYA)](/topic/$tnya) [Annexon, Inc. (ANNX)](/topic/$annx) [Structure Therapeutics Inc. (GPCR)](/topic/$gpcr) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Jade Biosciences, Inc. (JBIO)](/topic/$jbio) [Enliven Therapeutics, Inc. (ELVN)](/topic/$elvn) [Biofrontera Inc. (BFRI)](/topic/$bfri) [BioAge Labs, Inc. (BIOA)](/topic/$bioa)
### Top Social Posts
Top posts by engagements in the last [--] hours

"📋📊 $TERN Terns Pharmaceuticals Inc. announces $650 million public offering of [--------] shares at $40.00 per share On December [--] [----] Terns Pharmaceuticals Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999098395567308862)  2025-12-11T12:46Z [--] followers, [--] engagements


"$RAPP 8-K 📊 Rapport Therapeutics reports Phase 2a data for RAP-219 in drug-resistant focal seizures with 77.8% reduction and 72% responder rate. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/2012593/000119312526005446 http://sec.gov/Archives/edgar/data/2012593/000119312526005446"  
[X Link](https://x.com/booooogy01/status/2008880984226504773)  2026-01-07T12:38Z [--] followers, [--] engagements


"$ACTU 8-K 📊 Actuate Therapeutics reports positive follow-up data from Phase [--] trial with elraglusib plus chemotherapy in metastatic pancreatic cancer. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1652935/000168316826000217 http://sec.gov/Archives/edgar/data/1652935/000168316826000217"  
[X Link](https://x.com/booooogy01/status/2010821275577647312)  2026-01-12T21:08Z [--] followers, [--] engagements


"$SONN no longer exists. Biotech became crypto treasury $PURR overnight. $CAPR Phase [--] positive - both endpoints hit. This is what's in today's 8-Ks"  
[X Link](https://x.com/booooogy01/status/1996305975800734032)  2025-12-03T19:50Z [--] followers, [---] engagements


"Today in pharma 8-Ks: $CRSB - $185M raised. ADC pipeline funded to [----]. uniQure - FDA rejects Huntington data. No BLA. $KALA - $10M at $1. Survival financing. $GRDX - Pharma AI energy pivot. New CEO from power sector"  
[X Link](https://x.com/booooogy01/status/1996662572573933876)  2025-12-04T19:27Z [--] followers, [---] engagements


"📋 $CARM Carisma Therapeutics Inc. files 8-K regarding delisting and officer changes On December [--] [----] Carisma Therapeutics Inc. filed an 8-K report detailing a notice of delisting and changes in executive leadership. The filing includes informa #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997049916313542889)  2025-12-05T21:06Z [--] followers, [--] engagements


"🧪 PharmaStream test - 2025-12-05T21:10"  
[X Link](https://x.com/booooogy01/status/1997051047114580164)  2025-12-05T21:10Z [--] followers, [--] engagements


"📋 $ATYR aTYR PHARMA INC files 8-K regarding delisting notice aTYR PHARMA INC submitted an 8-K filing on December [--] [----] regarding a notice of delisting or failure to satisfy a continued listing rule. The filing is associated with the company's c #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997051165448564947)  2025-12-05T21:11Z [--] followers, [---] engagements


"📋 $SCLX Scilex Holding Co files 8-K regarding material agreements On December [--] [----] Scilex Holding Co filed an 8-K report detailing entry into a material definitive agreement and the creation of a direct financial obligation. The filing is asso #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997053395413107146)  2025-12-05T21:20Z [--] followers, [--] engagements


"📋 $IDYA IDEAYA Biosciences Inc. files 8-K on December [--] [----] IDEAYA Biosciences Inc. filed an 8-K report on December [--] [----] regarding other events. The filing is associated with SEC File Number 001-38915 and was submitted under the [----] Act. #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997054503707611574)  2025-12-05T21:24Z [--] followers, [---] engagements


"📋 $ADTX Aditxt Inc. files 8-K regarding delisting notice Aditxt Inc. filed an 8-K on December [--] [----] regarding a notice of delisting or failure to satisfy a continued listing rule. #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997057501087334683)  2025-12-05T21:36Z [--] followers, [---] engagements


"📋 $HURA TuHURA Biosciences Inc. files 8-K regarding material agreements TuHURA Biosciences Inc. filed an 8-K on December [--] [----] reporting entry into a material definitive agreement and creation of a direct financial obligation. #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997065106920820905)  2025-12-05T22:06Z [--] followers, [---] engagements


"📋 $PMCB PharmaCyte Biotech Inc. files 8-K regarding delisting PharmaCyte Biotech Inc. filed an 8-K on December [--] [----] indicating a notice of delisting or failure to satisfy a continued listing rule. #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1997066309763289240)  2025-12-05T22:11Z [--] followers, [---] engagements


"The #ASH25 data ($IMMX $APTOF) are bringing in capital. $LIXT is buying companies with Bitcoin $ADIA is changing its SIC code. The biotech market is splitting sharply between clinical validation and financial engineering"  
[X Link](https://x.com/booooogy01/status/1998130402113016200)  2025-12-08T20:39Z [--] followers, [---] engagements


"📋 $CLSDQ Clearside Biomedical Inc. reports notice of delisting On December [--] [----] Clearside Biomedical Inc. filed an 8-K regarding a notice of delisting or failure to satisfy a continued listing rule. #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1998144472295878739)  2025-12-08T21:35Z [--] followers, [--] engagements


"📋 $CLSDQ Clearside Biomedical Inc. Reports Notice of Delisting On December [--] [----] Clearside Biomedical Inc. filed an 8-K regarding a notice of delisting or failure to satisfy a continued listing rule. #SEC #8K #Pharma"  
[X Link](https://x.com/booooogy01/status/1998144487248560630)  2025-12-08T21:35Z [--] followers, [--] engagements


"📋 $QCLS Q/C Technologies Inc. Enters into Material Definitive Agreement and Welcomes Martin Shkreli as Strategic Advisor On December [--] [----] Q/C Technologies Inc. filed an 8-K reporting a consulting services agreement with Ocean Avenue Holdings LLC involving annual payment"  
[X Link](https://x.com/booooogy01/status/1998423649313783980)  2025-12-09T16:05Z [--] followers, [---] engagements


"📋 $XBIT John Simard retires as President and CEO of XBiotech Inc. effective December [--] [----] Sushma Shivaswamy appointed as interim CEO On December [--] [----] John Simard retired as President and CEO of XBiotech Inc. and will continue as Chairman of the Board. Sushma Shivaswam"  
[X Link](https://x.com/booooogy01/status/1998423883808985581)  2025-12-09T16:05Z [--] followers, [--] engagements


"🔴 $PDSB PDS Biotechnology Corp Secures New Patent for PDS0101 Amid Ongoing Phase [--] Trial On December [--] [----] PDS Biotechnology Corp announced that the Japan Patent Office issued a new composition of matter patent for PDS0101 which is currently being studied in a Phas #SEC #"  
[X Link](https://x.com/booooogy01/status/1998424119499489444)  2025-12-09T16:06Z [--] followers, [---] engagements


"🟢 $ELAN Elanco Animal Health Inc announces significant progress with Befrena and restructuring plans Elanco Animal Health Inc (ELAN) is expected to complete the administrative review and approval of its drug Befrena (tirnovetmab) for canine dermatitis by Q4 [----] following pos"  
[X Link](https://x.com/booooogy01/status/1998424588636856470)  2025-12-09T16:08Z [--] followers, [--] engagements


"🟢 $TNXP Tonix Pharmaceuticals Holding Corp. Receives FDA Approval for TONMYA for Fibromyalgia On December [--] [----] Tonix Pharmaceuticals Holding Corp. announced the FDA approval of TONMYA marking it as the first new prescription medicine approved for fibromyalgia in over [--] #"  
[X Link](https://x.com/booooogy01/status/1998424750067236960)  2025-12-09T16:09Z [--] followers, [---] engagements


"🟢🔥 $FENC FENNEC PHARMACEUTICALS INC. Announces Investigator-Sponsored Trial for PEDMARK Following Recent Approvals Fennec Pharmaceuticals Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998498778639380678)  2025-12-09T21:03Z [--] followers, [--] engagements


"🔴🔥 $ADVM Adverum Biotechnologies Completes Merger with Eli Lilly Becomes Wholly Owned Subsidiary On December [--] [----] Adverum Biotechnologies Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998498937720930726)  2025-12-09T21:04Z [--] followers, [---] engagements


"🔴🔥 $AVDL Avadel Pharmaceuticals PLC Reports Expiration of HSR Act Waiting Period for Acquisition by Alkermes PLC #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998502250864578936)  2025-12-09T21:17Z [--] followers, [---] engagements


"📋🔥 $APRE Aprea Therapeutics Inc. completes $3.1 million private placement On December [--] [----] Aprea Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998506060102119761)  2025-12-09T21:32Z [--] followers, [--] engagements


"📋🔥 $OTLC Oncotelic Therapeutics Inc. Completes Financing with $275000 Raised from Subscription Agreements Oncotelic Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998513871838232916)  2025-12-09T22:03Z [--] followers, [--] engagements


"📋📊 $VREOF Vireo Growth Inc. Completes Asset Sale of Schwazze's Assets for $111 Million On December [--] [----] Vireo Growth Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998724857605791929)  2025-12-10T12:01Z [--] followers, [---] engagements


"📋🔥 $ONCO Onconetix Inc. Amends License Agreement with Labcorp for Proclarix Study Onconetix Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998761970837893258)  2025-12-10T14:29Z [--] followers, [--] engagements


"🟢🔥 $RIGL Rigel Pharmaceuticals Inc reports R289 shows 33% efficacy in lower-risk MDS patients and receives FDA designations #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998862242838880555)  2025-12-10T21:07Z [--] followers, [--] engagements


"📋📊 $HURA TuHURA Biosciences Inc. raises $15612998 through securities purchase agreement On December [--] [----] TuHURA Biosciences Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998868474316410926)  2025-12-10T21:32Z [--] followers, [--] engagements


"🔴🔥 $CTOR CITIUS ONCOLOGY INC. Closes $18 Million Offering and Receives FDA Approval for LYMPHIR On December [--] [----] Citius Oncology Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998883153130434853)  2025-12-10T22:30Z [--] followers, [--] engagements


"🟢🔥 $IMVT Immunovant Inc. Announces $550 Million Underwritten Offering and Updates on IMVT-1402 Trials Immunovant Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999082219982221757)  2025-12-11T11:41Z [--] followers, [--] engagements


"🟢🔥 $ROIV Roivant Sciences Ltd. reports significant Phase [--] trial results for Brepocitinib in dermatomyositis Roivant Sciences Ltd. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999099280246657457)  2025-12-11T12:49Z [--] followers, [--] engagements


"🟢🔥 $RYTM Rhythm Pharmaceuticals Inc. Reports Positive Preliminary Results from Phase [--] Trial of Setmelanotide in PWS Rhythm Pharmaceuticals Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999099670241390978)  2025-12-11T12:51Z [--] followers, [---] engagements


"🔴🔥 $RNAZ Transcode Therapeutics Inc. announces Phase 2a trial launch for TTX-MC138 in partnership with Quantum Leap Healthcare Collaborative On December [--] [----] Transcode Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999104734335283204)  2025-12-11T13:11Z [--] followers, [--] engagements


"🔴🔥 $PHGE BiomX Inc. discontinues Phase 2b study and initiates insolvency proceedings for BiomX Ltd. On December [--] [----] BiomX Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999224597212987758)  2025-12-11T21:07Z [--] followers, [---] engagements


"📋📊 $RNTX Rein Therapeutics Inc. terminates $3 million Pre-Paid Advance Agreement with Yorkville On December [--] [----] Rein Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999243389204865042)  2025-12-11T22:22Z [--] followers, [--] engagements


"📋📊 $THAR Tharimmune Inc. Appoints Jacob Asbury as Chief Financial Officer with $300000 Salary On December [--] [----] Tharimmune Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999520857472008289)  2025-12-12T16:44Z [--] followers, [--] engagements


"🔴🔥 $BCRX BioCryst Pharmaceuticals Inc Receives FDA Approval for ORLADEYO (berotralstat) Oral Pellets #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999521211118944686)  2025-12-12T16:46Z [--] followers, [--] engagements


"🔴🔥 $IDYA IDEAYA Biosciences Inc. (IDYA) announces termination of collaboration with GSK effective March [--] [----]. On December [--] [----] IDEAYA Biosciences Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999586927230832852)  2025-12-12T21:07Z [--] followers, [--] engagements


"📋📊 $SBFM Sunshine Biopharma Inc. Elects New Directors and Ratifies Accounting Firm On December [--] [----] Sunshine Biopharma Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999587069354729593)  2025-12-12T21:08Z [--] followers, [---] engagements


"📋🔥 $CDT CDT Equity Inc. enters into a Sale and Purchase Agreement to transfer Conduit Pharmaceuticals Limited for $7000000 On December [--] [----] CDT Equity Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999589497856754002)  2025-12-12T21:17Z [--] followers, [--] engagements


"📋📊 $IMVT Immunovant Inc. completes underwritten offering raising approximately $550 million On December [--] [----] Immunovant Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999589610327015720)  2025-12-12T21:18Z [--] followers, [--] engagements


"📋📊 $BHC Bausch Health Companies Inc. announces refinancing of $2.8 billion in term B loans Bausch Health Companies Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999608060889956385)  2025-12-12T22:31Z [--] followers, [--] engagements


"$RLMD RELMADA THERAPEUTICS 8-K Relmada Therapeutics Inc. Amends Employment Agreements for Executive Officers with Salary Increases 📊 NEUTRAL: SEC disclosure provides transparency on material events 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1553643/000121390025121461 http://sec.gov/Archives/edgar/data/1553643/000121390025121461"  
[X Link](https://x.com/booooogy01/status/2000549318546321500)  2025-12-15T12:51Z [--] followers, [--] engagements


"$FBIO Fortress Biotech 8-K Fortress Biotech Inc. Announces FDA Acceptance of CUTX-101 NDA Resubmission with PDUFA Date Set for January [--] [----] 🔴 BEARISH: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1429260/000110465925120893 http://sec.gov/Archives/edgar/data/1429260/000110465925120893"  
[X Link](https://x.com/booooogy01/status/2000560789359587509)  2025-12-15T13:37Z [--] followers, [--] engagements


"$MIST Milestone Pharmaceuticals 8-K Milestone Pharmaceuticals Inc. Receives FDA Approval for CARDAMYST and Secures $75 Million Financing 🟢 BULLISH: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1408443/000110465925120904 http://sec.gov/Archives/edgar/data/1408443/000110465925120904"  
[X Link](https://x.com/booooogy01/status/2000566949101838564)  2025-12-15T14:01Z [--] followers, [---] engagements


"$INM InMed Pharmaceuticals New 8-K filing #Pharma #8K"  
[X Link](https://x.com/booooogy01/status/2000575681139450357)  2025-12-15T14:36Z [--] followers, [--] engagements


"$MBRX 8-K 📊 Moleculin Biotech receives Nasdaq delisting notice From the filing: [--] active PHASE3 trial for drug A Pipeline: [--] active trial 🔴 Data Assessment: NEGATIVE 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1659617/000143774925038478 http://sec.gov/Archives/edgar/data/1659617/000143774925038478"  
[X Link](https://x.com/booooogy01/status/2003106306719170755)  2025-12-22T14:12Z [--] followers, [---] engagements


"$COLL 8-K 📊 Collegium closes $980M credit facility. [--] active clinical trials for H EMA: News Pipeline: [--] active trials 🔴 Data Assessment: NEGATIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1267565/000110465925125026 http://sec.gov/Archives/edgar/data/1267565/000110465925125026"  
[X Link](https://x.com/booooogy01/status/2005990216683626910)  2025-12-30T13:11Z [--] followers, [--] engagements


"$MDCX 8-K 📊 Medicus Pharma Ltd. establishes at-the-market equity program for up to $15349674. From the filing: Aggregate offering amount: $15349674 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1997296/000106299325017492 http://sec.gov/Archives/edgar/data/1997296/000106299325017492"  
[X Link](https://x.com/booooogy01/status/2006010736729022822)  2025-12-30T14:33Z [--] followers, [--] engagements


"$CYPH 8-K 📊 CYPHERPUNK TECHNOLOGIES INC. grants [-------] RSUs to CoinXit Ltd. From the filing: Total amount: $5448157 RSUs 🔴 Data Assessment: NEGATIVE 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1509745/000110465925125224 http://sec.gov/Archives/edgar/data/1509745/000110465925125224"  
[X Link](https://x.com/booooogy01/status/2006112673294090550)  2025-12-30T21:18Z [--] followers, [--] engagements


"$VREOF 8-K 📊 Vireo Growth Inc. announces acquisition of Eaze Inc. for $47.0 million Total amount: $47.0 million 🔴 Data Assessment: NEGATIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1771706/000110465925125248 http://sec.gov/Archives/edgar/data/1771706/000110465925125248"  
[X Link](https://x.com/booooogy01/status/2006116474818265193)  2025-12-30T21:33Z [--] followers, [---] engagements


"$OTLC 8-K 📊 Oncotelic Therapeutics completes private placement of $800000 From the filing: Total amount: $800000 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/908259/000149315225029634 http://sec.gov/Archives/edgar/data/908259/000149315225029634"  
[X Link](https://x.com/booooogy01/status/2006126018394980820)  2025-12-30T22:11Z [--] followers, [--] engagements


"$BCAB 8-K 📊 BioAtla announces $40M SPV transaction to advance Ozuriftamab Vedotin into registrational trial for 2L+ Oropharyngeal Squamous Cell Carcinoma 📊 Data Assessment: NEUTRAL 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1826892/000119312525337646 http://sec.gov/Archives/edgar/data/1826892/000119312525337646"  
[X Link](https://x.com/booooogy01/status/2006340026565881881)  2025-12-31T12:21Z [--] followers, [---] engagements


"$CORT 8-K 📊 FDA issues Complete Response Letter for relacorilant a treatment for hypercortisolism From the filing: Relacorilant therapeutic class: cortisol modulator Pipeline: no data 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1088856/000119312525338184 http://sec.gov/Archives/edgar/data/1088856/000119312525338184 http://sec.gov/Archives/edgar/data/1088856/000119312525338184 http://sec.gov/Archives/edgar/data/1088856/000119312525338184"  
[X Link](https://x.com/booooogy01/status/2006455023107219511)  2025-12-31T19:58Z [--] followers, [--] engagements


"$LIXT 8-K 📊 Lixte Biotechnology entered into a Share Exchange Agreement with Orbit Capital Inc. Exchanged [----] Series C Preferred Stock for [------] common stock [--] active clinical trials 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1335105/000149315225029778 http://sec.gov/Archives/edgar/data/1335105/000149315225029778 http://sec.gov/Archives/edgar/data/1335105/000149315225029778 http://sec.gov/Archives/edgar/data/1335105/000149315225029778"  
[X Link](https://x.com/booooogy01/status/2006472554886869241)  2025-12-31T21:08Z [--] followers, [--] engagements


"$TNGX 8-K 📊 Tango Therapeutics appoints Sung Lee to Board of Directors plans to advance Vopimetostat into registrational studies 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1819133/000119312526001495 http://sec.gov/Archives/edgar/data/1819133/000119312526001495"  
[X Link](https://x.com/booooogy01/status/2008149438695428416)  2026-01-05T12:11Z [--] followers, [--] engagements


"$MEHA 8-K 📊 Functional Brands Inc. repurchases Series A Convertible Preferred Stock for $180330 From the filing: Repurchase amount: $180330 📊 Data Assessment: NEUTRAL 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1837254/000121390026001247 http://sec.gov/Archives/edgar/data/1837254/000121390026001247"  
[X Link](https://x.com/booooogy01/status/2008300483564499000)  2026-01-05T22:12Z [--] followers, [---] engagements


"$ABP Abpro Holdings 8-K Abpro Holdings Inc. Announces FDA Clearance of IND Application for ABP-102 / CT-P72 📊 NEUTRAL: Trial results shape development path and investor confidence 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1893219/000121390026001570 http://sec.gov/Archives/edgar/data/1893219/000121390026001570"  
[X Link](https://x.com/booooogy01/status/2008512023651324099)  2026-01-06T12:12Z [--] followers, [--] engagements


"$ACRS 8-K 📊 Aclaris Therapeutics announces positive Phase 1a trial results for ATI-052 in asthma and atopic dermatitis From the filing: Drug: ATI-052 Pipeline: Not specified 📊 Data Assessment: NEUTRAL 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1557746/000110465926001076 http://sec.gov/Archives/edgar/data/1557746/000110465926001076"  
[X Link](https://x.com/booooogy01/status/2008514199580799291)  2026-01-06T12:21Z [--] followers, [--] engagements


"$KALA 8-K 📊 KALA BIO settles $10.6M of debt via settlement agreements From the filing: Debt reduction Pipeline: Not specified 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1479419/000182912626000055 http://sec.gov/Archives/edgar/data/1479419/000182912626000055"  
[X Link](https://x.com/booooogy01/status/2008519366715879452)  2026-01-06T12:41Z [--] followers, [--] engagements


"$MIST Milestone Pharmaceuticals 8-K Milestone Pharmaceuticals Inc. Announces EMA Acceptance of MAA for Etripamil Nasal Spray for PSVT 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🧬 PHASE3: [--] active clinical trials 💊 Drug: C o 🎯 Indication: E 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1408443/000110465926001099 http://sec.gov/Archives/edgar/data/1408443/000110465926001099"  
[X Link](https://x.com/booooogy01/status/2008528299291525362)  2026-01-06T13:17Z [--] followers, [---] engagements


"$ATOS ATOSSA THERAPEUTICS 8-K Atossa Therapeutics Receives FDA 'Study May Proceed' Letter for (Z)-Endoxifen in Metastatic Breast Cancer 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1488039/000119312526003506 http://sec.gov/Archives/edgar/data/1488039/000119312526003506"  
[X Link](https://x.com/booooogy01/status/2008537201140003242)  2026-01-06T13:52Z [--] followers, [--] engagements


"$OTLC 8-K 📊 Oncotelic Therapeutics completes $1.1M private placement with 12% notes convertible at $0.10/share 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/908259/000149315226000613 http://sec.gov/Archives/edgar/data/908259/000149315226000613"  
[X Link](https://x.com/booooogy01/status/2008654941976727917)  2026-01-06T21:40Z [--] followers, [--] engagements


"$IONS 8-K 📊 Ionis Pharmaceuticals announces positive Phase [--] topline results for bepirovirsen in chronic hepatitis B. From the filing: [--] active clinical trials 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/874015/000114036126000435 http://sec.gov/Archives/edgar/data/874015/000114036126000435"  
[X Link](https://x.com/booooogy01/status/2008858771054059985)  2026-01-07T11:10Z [--] followers, [---] engagements


"$SABS 8-K 📊 SAB Biotherapeutics appoints David Zaccardelli as Board Chair and Rita Jain as independent director 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1833214/000119312526005487 http://sec.gov/Archives/edgar/data/1833214/000119312526005487"  
[X Link](https://x.com/booooogy01/status/2008897567879508301)  2026-01-07T13:44Z [--] followers, [--] engagements


"$ACET 8-K 📊 Adicet Bio reports positive Phase [--] data for prula-cel receives FDA Fast Track designation and secures $74.8M financing. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1720580/000119312526005486 http://sec.gov/Archives/edgar/data/1720580/000119312526005486"  
[X Link](https://x.com/booooogy01/status/2008900008515707352)  2026-01-07T13:54Z [--] followers, [--] engagements


"$CDTX 8-K 📊 Cidara Therapeutics acquired by Merck Sharp & Dohme LLC for $221.50 per share now a wholly owned subsidiary. 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1610618/000119312526005517 http://sec.gov/Archives/edgar/data/1610618/000119312526005517"  
[X Link](https://x.com/booooogy01/status/2008903548587880624)  2026-01-07T14:08Z [--] followers, [--] engagements


"$PHAT 8-K 📊 Phathom reports $175M preliminary [----] revenue. [--] active clinical trials Pipeline: [--] active trials 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1783183/000119312526006266 http://sec.gov/Archives/edgar/data/1783183/000119312526006266"  
[X Link](https://x.com/booooogy01/status/2009009785551900902)  2026-01-07T21:10Z [--] followers, [--] engagements


"$PHGE 8-K 📊 BiomX Inc. subsidiary terminates lease pays $800k settlement From the filing: Settlement amount: $800k 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1739174/000121390026002160 http://sec.gov/Archives/edgar/data/1739174/000121390026002160"  
[X Link](https://x.com/booooogy01/status/2009011651547464187)  2026-01-07T21:17Z [--] followers, [--] engagements


"$FGEN 8-K 📊 Kyntra Bio reports clinical progress with FG-3246 in Phase [--] roxadustat receives Orphan Drug Designation and extends cash runway to [----] 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/921299/000119312526006327 http://sec.gov/Archives/edgar/data/921299/000119312526006327"  
[X Link](https://x.com/booooogy01/status/2009014982369775659)  2026-01-07T21:31Z [--] followers, [--] engagements


"$GRDX 8-K 📊 GridAI unwinds ImmunogenX acquisition From the filing: Rescission complete Acquisition unwound 🔴 Data Assessment: NEGATIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1604191/000110465926001755 http://sec.gov/Archives/edgar/data/1604191/000110465926001755"  
[X Link](https://x.com/booooogy01/status/2009015349757252002)  2026-01-07T21:32Z [--] followers, [--] engagements


"$OTLC Oncotelic Therapeutics 8-K Oncotelic Therapeutics amends agreements lowering CEO market cap milestone threshold from $100M to $45M 📊 NEUTRAL: SEC disclosure provides transparency on material events 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/908259/000149315226000821 http://sec.gov/Archives/edgar/data/908259/000149315226000821"  
[X Link](https://x.com/booooogy01/status/2009017457621536876)  2026-01-07T21:41Z [--] followers, [--] engagements


"$CRNX 8-K 📊 Crinetics announces FDA approval of PALSONIFY (paltusotine) & $350M public offering From the filing: [--] active clinical trials Pipeline: [--] active trials 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1658247/000119312526006421 http://sec.gov/Archives/edgar/data/1658247/000119312526006421"  
[X Link](https://x.com/booooogy01/status/2009018548861980919)  2026-01-07T21:45Z [--] followers, [--] engagements


"$CERO 8-K 📊 CERO Therapeutics reports positive early safety data for CER-1236 in AML filing to expand Phase [--] trial to MDS and myelofibrosis. 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1870404/000121390026002187 http://sec.gov/Archives/edgar/data/1870404/000121390026002187"  
[X Link](https://x.com/booooogy01/status/2009019091420377549)  2026-01-07T21:47Z [--] followers, [--] engagements


"$PPCB 8-K 📊 Propanc Biopharma receives Nasdaq delisting notice for failing to maintain minimum $1.00 bid price. 🔴 Data Assessment: NEGATIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1517681/000149315226000834 http://sec.gov/Archives/edgar/data/1517681/000149315226000834"  
[X Link](https://x.com/booooogy01/status/2009025425335332906)  2026-01-07T22:12Z [--] followers, [--] engagements


"$COLL COLLEGIUM PHARMACEUTICAL 8-K Collegium provides [----] financial guidance 📊 NEUTRAL: SEC disclosure provides transparency on material events 💰 Deal value: $$805 - 825M 🧬 PHASE3: [--] active clinical trials 💊 Drug: C M 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1267565/000110465926001953 http://sec.gov/Archives/edgar/data/1267565/000110465926001953 http://sec.gov/Archives/edgar/data/1267565/000110465926001953 http://sec.gov/Archives/edgar/data/1267565/000110465926001953"  
[X Link](https://x.com/booooogy01/status/2009259060710019391)  2026-01-08T13:41Z [--] followers, [--] engagements


"$TNGX Tango Therapeutics 8-K Tango Therapeutics reports positive vopimetostat data (27% ORR [--]. 📊 NEUTRAL: Trial results shape development path and investor confidence 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1819133/000119312526007086 http://sec.gov/Archives/edgar/data/1819133/000119312526007086"  
[X Link](https://x.com/booooogy01/status/2009269561762435330)  2026-01-08T14:22Z [--] followers, [--] engagements


"$MLTX MoonLake Immunotherape. 8-K MoonLake Immunotherapeutics receives positive FDA Type B meeting feedback confirming BLA pathway for sonelokimab in. 🟢 BULLISH: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1821586/000121390026002344 http://sec.gov/Archives/edgar/data/1821586/000121390026002344 http://sec.gov/Archives/edgar/data/1821586/000121390026002344 http://sec.gov/Archives/edgar/data/1821586/000121390026002344"  
[X Link](https://x.com/booooogy01/status/2009274523007529033)  2026-01-08T14:42Z [--] followers, [---] engagements


"$VNRX VOLITIONRX 8-K VolitionRx (VNRX) enters amended $2M financing agreement with Lind Global via convertible note and warrant 📊 NEUTRAL: Capital raise extends runway and funds development programs 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/93314/000147793226000107 http://sec.gov/Archives/edgar/data/93314/000147793226000107"  
[X Link](https://x.com/booooogy01/status/2009393389234794776)  2026-01-08T22:34Z [--] followers, [--] engagements


"$RYTM 8-K 📊 Rhythm Pharmaceuticals reports Phase [--] results for setmelanotide. From the filing: [--] active clinical trials 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1649904/000162828026001459 http://sec.gov/Archives/edgar/data/1649904/000162828026001459"  
[X Link](https://x.com/booooogy01/status/2009669635768234215)  2026-01-09T16:52Z [--] followers, [--] engagements


"$NTLA Intellia Therapeutics 8-K Intellia (NTLA) reports lonvo-z Phase [--] fully enrolled (data mid-2026) but nex-z Phase [--] trials on clinical hold due to. 📊 NEUTRAL: Trial results shape development path and investor confidence 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1652130/000119312526008307 http://sec.gov/Archives/edgar/data/1652130/000119312526008307 http://sec.gov/Archives/edgar/data/1652130/000119312526008307 http://sec.gov/Archives/edgar/data/1652130/000119312526008307"  
[X Link](https://x.com/booooogy01/status/2009673813169250578)  2026-01-09T17:09Z [--] followers, [---] engagements


"$SVRA Savara 8-K Savara Inc (SVRA) Announces Positive Phase [--] IMPALA-2 Results for MOLBREEVI BLA Submitted to FDA in Dec [----] 🟢 BULLISH: Trial results shape development path and investor confidence 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1160308/000119312526008301 http://sec.gov/Archives/edgar/data/1160308/000119312526008301"  
[X Link](https://x.com/booooogy01/status/2009674807911297116)  2026-01-09T17:13Z [--] followers, [--] engagements


"$IOVA IOVANCE BIOTHERAPEUTICS 8-K Iovance Biotherapeutics announces FDA approval of Amtagvi for advanced melanoma and reports strong Phase [--] data for. 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1425205/000110465926002323 http://sec.gov/Archives/edgar/data/1425205/000110465926002323 http://sec.gov/Archives/edgar/data/1425205/000110465926002323 http://sec.gov/Archives/edgar/data/1425205/000110465926002323"  
[X Link](https://x.com/booooogy01/status/2009676856002281711)  2026-01-09T17:21Z [--] followers, [---] engagements


"$HRTX 8-K 📊 Heron Therapeutics reports Q4 [----] net revenue of $40.5M FY [----] revenue of $154.9M. [--] active clinical trial 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/818033/000119312526008631 http://sec.gov/Archives/edgar/data/818033/000119312526008631"  
[X Link](https://x.com/booooogy01/status/2009711665659416990)  2026-01-09T19:39Z [--] followers, [--] engagements


"$IDYA 8-K 📊 IDEAYA Biosciences reports positive Phase 2/3 survival data for Darovasertib in uveal melanoma and 73.2% ORR for IDE849 in small cell lung cancer 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1676725/000119312526009641 http://sec.gov/Archives/edgar/data/1676725/000119312526009641"  
[X Link](https://x.com/booooogy01/status/2010671160812257767)  2026-01-12T11:12Z [--] followers, [--] engagements


"$ACRS 8-K 📊 Aclaris Therapeutics reports positive Phase 2a and Phase 1a data for Bosakitug ATI-052 and ATI-2138 in atopic dermatitis. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1557746/000110465926002694 http://sec.gov/Archives/edgar/data/1557746/000110465926002694"  
[X Link](https://x.com/booooogy01/status/2010684243559510359)  2026-01-12T12:04Z [--] followers, [--] engagements


"$KPTI 8-K 📊 Karyopharm announces upcoming Phase [--] data readouts in myelofibrosis and endometrial cancer with financing extending cash runway to Q2 [----] 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1503802/000119312526009738 http://sec.gov/Archives/edgar/data/1503802/000119312526009738"  
[X Link](https://x.com/booooogy01/status/2010685020562731282)  2026-01-12T12:07Z [--] followers, [--] engagements


"$BTAI 8-K 📊 BioXcel Therapeutics plans sNDA submission for IGALMI for at-home use in agitation associated with bipolar disorder or schizophrenia. From the filing: Therapeutic area: Psychiatry 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1720893/000110465926002697 http://sec.gov/Archives/edgar/data/1720893/000110465926002697 http://sec.gov/Archives/edgar/data/1720893/000110465926002697 http://sec.gov/Archives/edgar/data/1720893/000110465926002697"  
[X Link](https://x.com/booooogy01/status/2010685317540413892)  2026-01-12T12:08Z [--] followers, [--] engagements


"$MRNA 8-K 📊 Moderna anticipates potential [----] approvals for flu and combination vaccines secures $1.5 billion loan. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1682852/000168285226000007 http://sec.gov/Archives/edgar/data/1682852/000168285226000007"  
[X Link](https://x.com/booooogy01/status/2010686223690391721)  2026-01-12T12:12Z [--] followers, [--] engagements


"$IONS 8-K 📊 Ionis reports FDA approvals and $105M in [----] sales. From the filing: [--] active clinical trials Pipeline: [--] active trials 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/874015/000114036126000893 http://sec.gov/Archives/edgar/data/874015/000114036126000893"  
[X Link](https://x.com/booooogy01/status/2010687465250578650)  2026-01-12T12:17Z [--] followers, [--] engagements


"$PVLA PALVELLA THERAPEUTICS 8-K Palvella Therapeutics Reports Positive Phase [--] Results for QTORIN in Lymphatic and Venous Malformations Receives FDA. 📊 NEUTRAL: Trial results shape development path and investor confidence 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1583648/000119312526009724 http://sec.gov/Archives/edgar/data/1583648/000119312526009724 http://sec.gov/Archives/edgar/data/1583648/000119312526009724 http://sec.gov/Archives/edgar/data/1583648/000119312526009724"  
[X Link](https://x.com/booooogy01/status/2010688789450981514)  2026-01-12T12:22Z [--] followers, [--] engagements


"$TRAW 8-K 📊 Traws Pharma reports positive interim Phase [--] data for ratutrelvir in COVID-19 with faster symptom resolution. From the filing: Drug: ratutrelvir tivoxavir marboxil Indications: COVID-19 influenza 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1130598/000110465926003071 http://sec.gov/Archives/edgar/data/1130598/000110465926003071"  
[X Link](https://x.com/booooogy01/status/2011047441433272369)  2026-01-13T12:07Z [--] followers, [--] engagements


"$QURE 8-K 📊 uniQure reports 36-month Phase I/II data for AMT-130 in Huntington's disease with 75% reduction in disease progression. From the filing: Engagement with FDA on accelerated approval pathway 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1590560/000110465926003075 http://sec.gov/Archives/edgar/data/1590560/000110465926003075 http://sec.gov/Archives/edgar/data/1590560/000110465926003075 http://sec.gov/Archives/edgar/data/1590560/000110465926003075"  
[X Link](https://x.com/booooogy01/status/2011049135504298054)  2026-01-13T12:14Z [--] followers, [---] engagements


"$CRNX 8-K 📊 Crinetics reports positive Phase [--] data initiates Phase [--] trials for F From the filing: [--] active clinical trials Pipeline: [--] active trials 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1658247/000119312526011872 http://sec.gov/Archives/edgar/data/1658247/000119312526011872"  
[X Link](https://x.com/booooogy01/status/2011198272468124112)  2026-01-13T22:06Z [--] followers, [--] engagements


"$ESLA Estrella Immunopharma 8-K Estrella Immunopharma Receives Nasdaq Non-Compliance Notice for Failure to Hold Annual Shareholder Meeting 🔴 BEARISH: SEC disclosure provides transparency on material events 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1844417/000121390026003998 http://sec.gov/Archives/edgar/data/1844417/000121390026003998"  
[X Link](https://x.com/booooogy01/status/2011203192231526799)  2026-01-13T22:26Z [--] followers, [--] engagements


"$IBRX 8-K 📊 ImmunityBio receives SFDA accelerated approval for ANKTIVA in bladder cancer. From the filing: Drug: ANKTIVA Indication: bladder cancer 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1326110/000132611026000004 http://sec.gov/Archives/edgar/data/1326110/000132611026000004"  
[X Link](https://x.com/booooogy01/status/2011435931262505396)  2026-01-14T13:51Z [--] followers, [----] engagements


"$OCGN 8-K 📊 Ocugen reports positive Phase 1/2 data for three gene therapies advancing to Phase [--] trials with BLA submissions planned from 2026-2028 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1372299/000110465926003900 http://sec.gov/Archives/edgar/data/1372299/000110465926003900"  
[X Link](https://x.com/booooogy01/status/2011795967314706765)  2026-01-15T13:41Z [--] followers, [---] engagements


"$IBRX 8-K 📊 ImmunityBio reports $113M in [----] revenue. ANKTIVA receives Saudi FDA approvals for NSCLC and bladder cancer. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1326110/000132611026000008 http://sec.gov/Archives/edgar/data/1326110/000132611026000008"  
[X Link](https://x.com/booooogy01/status/2011796899440050547)  2026-01-15T13:45Z [--] followers, [---] engagements


"$JAGX 8-K 📊 Jaguar Health enters US licensing deal with Future Pak for Mytesi & Canalevia-CA1 with up to $38M in payments. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1585608/000119312526014231 http://sec.gov/Archives/edgar/data/1585608/000119312526014231"  
[X Link](https://x.com/booooogy01/status/2011925519382806791)  2026-01-15T22:16Z [--] followers, [---] engagements


"$AVDL - Alkermes acquisition hearing set Court date is Feb [--]. Avadel has [--] active Phase [--] trials ongoing waiting on this deal to close"  
[X Link](https://x.com/booooogy01/status/2013568953419997652)  2026-01-20T11:07Z [--] followers, [--] engagements


"$NVAX - Pfizer licensing deal announced $30M upfront up to $530M in milestones for Matrix-M adjuvant. They've got [--] active Phase [--] trial ongoing. Stock's up 10% today"  
[X Link](https://x.com/booooogy01/status/2013582807554200048)  2026-01-20T12:02Z [--] followers, [---] engagements


"@Czarus7777 Let them dig their own grave. This news just adds more fuel for a massive squeeze later. Theyre playing with fire now. $NVAX #ShortSqueeze #Pfizer #Biotech"  
[X Link](https://x.com/booooogy01/status/2013595448301224201)  2026-01-20T12:52Z [--] followers, [--] engagements


"$ENGN - enGene secures $125 million debt facility with Hercules Capital; detalimogene gains RMAT and Fast Track designations Routine update"  
[X Link](https://x.com/booooogy01/status/2013955302719111251)  2026-01-21T12:42Z [--] followers, [--] engagements


"$AEON - Met with FDA on ABP-450 biosimilar [--] active clinical trials ongoing mostly in Phase [--] and [--]. Stock's up 22% today PIPE financing close expected soon"  
[X Link](https://x.com/booooogy01/status/2014084181844959495)  2026-01-21T21:14Z [--] followers, [--] engagements


"$OCGN - priced $22.5M stock offering at $1.50 Stock's down 22% today closes tomorrow. Needed cash but dilution's a concern now"  
[X Link](https://x.com/booooogy01/status/2014103665284620475)  2026-01-21T22:31Z [--] followers, [---] engagements


"$CORT - Relacorilant Phase [--] looks good 85% reduction in adrenal insufficiency. Sets them up nicely for July [--] FDA decision"  
[X Link](https://x.com/booooogy01/status/2014326460345897163)  2026-01-22T13:17Z [--] followers, [---] engagements


"$OGEN - Amended ATM agreement Extended term for at-the-market stock sales gives them more flexibility to raise cash. Stock's up 1.41% today likely a reaction to this news"  
[X Link](https://x.com/booooogy01/status/2014446433823523309)  2026-01-22T21:13Z [--] followers, [--] engagements


"$PLUR - Nasdaq delisting notice arrived Got a July deadline to hit $35M market value or risk getting booted. Stock's up 7% today but that's a tough climb"  
[X Link](https://x.com/booooogy01/status/2014446767904063833)  2026-01-22T21:15Z [--] followers, [--] engagements


"$ORGS - Took $1M loan from Alpha Prosperity Issued 3.29M share warrant trades on OTC. Stock's up 18.75% today warrant expires Jan 2029"  
[X Link](https://x.com/booooogy01/status/2015747078182326707)  2026-01-26T11:22Z [--] followers, [--] engagements


"📋📊 $INMB Inmune Bio Inc. terminates At-The-Market Sales Agreement and raises $10.5 million On December [--] [----] Inmune Bio Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998860724744106090)  2025-12-10T21:01Z [--] followers, [---] engagements


"📋📊 $PMHS Polomar Health Services Inc. Secures $750000 Guaranteed Payment and Extends Exclusivity for Inhalable Products Polomar Health Services Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999598437164323050)  2025-12-12T21:53Z [--] followers, [--] engagements


"$BFRG BullFrog AI Holdings 8-K BullFrog AI enters into a commercial collaboration with Sygnature Discovery expected to generate significant revenue. 🔴 BEARISH: SEC disclosure provides transparency on material events 💰 Deal value: $significant revenue through [----] 🤝 Partner: Sygnature Discovery Eleison Pharmaceuticals 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1829247/000149315225029636 http://sec.gov/Archives/edgar/data/1829247/000149315225029636"  
[X Link](https://x.com/booooogy01/status/2006125293535416465)  2025-12-30T22:08Z [--] followers, [--] engagements


"$DNLI Denali Therapeutics 8-K Denali Therapeutics Secures FDA Accelerated Approval for Tividenofusp Alfa and Completes $200 Million Financing 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1714899/000171489926000004 http://sec.gov/Archives/edgar/data/1714899/000171489926000004"  
[X Link](https://x.com/booooogy01/status/2008532120940024108)  2026-01-06T13:32Z [--] followers, [---] engagements


"$MRSN Mersana Therapeutics 8-K Mersana Therapeutics Completes Merger with Day One Biopharmaceuticals Subject to FDA Approval and Nasdaq Delisting 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1442836/000110465926001125 http://sec.gov/Archives/edgar/data/1442836/000110465926001125"  
[X Link](https://x.com/booooogy01/status/2008549506900783568)  2026-01-06T14:41Z [--] followers, [--] engagements


"$REGN 8-K 📊 Regeneron reports 100% MRD-negativity with Lynozyfic. From the filing: [--] active clinical trials 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/872589/000110465926002691 http://sec.gov/Archives/edgar/data/872589/000110465926002691"  
[X Link](https://x.com/booooogy01/status/2010681361502237035)  2026-01-12T11:52Z [--] followers, [---] engagements


"$BBIO - Prices $550M convertible note offering Prefunding [----] debt first interest payment due Aug [--]. Gives them some breathing room but dilution risk is on the table now"  
[X Link](https://x.com/booooogy01/status/2014083754848026966)  2026-01-21T21:12Z [--] followers, [---] engagements


"$CDT - Secured $25M equity line Issued [------] commitment shares to Ascent Partners. No immediate change in stock price but gives them some breathing room. Resale registration statement due out in about [--] days"  
[X Link](https://x.com/booooogy01/status/2014448802837479859)  2026-01-22T21:23Z [--] followers, [---] engagements


"$STOK - Inks $85.5M lease for new HQ and lab space in Waltham. Big commitment but they've got until [----] to make it work"  
[X Link](https://x.com/booooogy01/status/2015896130492760540)  2026-01-26T21:14Z [--] followers, [--] engagements


"$NTLA - Intellia Therapeutics: FDA Lifts Clinical Hold on MAGNITUDE-2 Phase [--] Trial for nexiguran ziclumeran in ATTRv-PN FYI"  
[X Link](https://x.com/booooogy01/status/2016139561517384150)  2026-01-27T13:21Z [--] followers, [---] engagements


"$CRDF - Phase [--] mCRC data out 72.2% ORR and decent PFS numbers but stock's getting slammed. Final data and registrational plans due in H1 2026"  
[X Link](https://x.com/booooogy01/status/2016256678157570168)  2026-01-27T21:07Z [--] followers, [---] engagements


"📋🔥 $PLUR Pluri Inc. Raises $2.5 Million Through Private Placement Offering Pluri Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998498508693975155)  2025-12-09T21:02Z [--] followers, [--] engagements


"📋📊 $DYN Dyne Therapeutics announces pricing of upsized $350.0 million public offering of common stock On December [--] [----] Dyne Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998866394897854769)  2025-12-10T21:24Z [--] followers, [--] engagements


"📋📊 $KYMR Kymera Therapeutics Inc. announces pricing of $602 million public offering On December [--] [----] Kymera Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998880236084277671)  2025-12-10T22:19Z [--] followers, [--] engagements


"📋📊 $CTNM Contineum Therapeutics Inc. submits Phase [--] clinical trial details for PIPE-791 targeting idiopathic pulmonary fibrosis On December [--] [----] Contineum Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999223277584355502)  2025-12-11T21:02Z [--] followers, [--] engagements


"$CGC Canopy Growth 8-K Canopy Growth Corp Appoints Michael Perron as Chief Operating Officer with CAD $50000 Equity Grant 📊 NEUTRAL: SEC disclosure provides transparency on material events 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1737927/000110465925120861 http://sec.gov/Archives/edgar/data/1737927/000110465925120861"  
[X Link](https://x.com/booooogy01/status/2000541757919150416)  2025-12-15T12:21Z [--] followers, [---] engagements


"$PYXS 8-K 📊 Pyxis Oncology reports strong clinical activity of MICVO in R/M HNSCC. Confirmed ORR: 46% DCR: 92% Pipeline: [--] active trials in PHASE3 🟢 Data Assessment: POSITIVE 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1782223/000119312525323704 http://sec.gov/Archives/edgar/data/1782223/000119312525323704"  
[X Link](https://x.com/booooogy01/status/2001632840065388613)  2025-12-18T12:37Z [--] followers, [---] engagements


"$FLGC 8-K 📊 Flora Growth settles convertible note with DeFi Development Corp. for $1750000 cash [------] common shares at $6.90 and $96161.91 in Solana. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1790169/000106299325017540 http://sec.gov/Archives/edgar/data/1790169/000106299325017540"  
[X Link](https://x.com/booooogy01/status/2006476307182530688)  2025-12-31T21:23Z [--] followers, [--] engagements


"$GYRE 8-K 📊 Gyre Therapeutics announces Phase [--] results for Hydronidone with conditional approval pathway in China From the filing: Positive Phase [--] results Pipeline: Not specified 📊 Data Assessment: NEUTRAL 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1124105/000114036126000253 http://sec.gov/Archives/edgar/data/1124105/000114036126000253"  
[X Link](https://x.com/booooogy01/status/2008150699830366370)  2026-01-05T12:16Z [--] followers, [---] engagements


"$ALKS Alkermes plc. 8-K Alkermes plc Receives Breakthrough Therapy Designation for Alixorexton in Narcolepsy Type [--] 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1520262/000119312526003453 http://sec.gov/Archives/edgar/data/1520262/000119312526003453"  
[X Link](https://x.com/booooogy01/status/2008511749452915118)  2026-01-06T12:11Z [--] followers, [--] engagements


"$MBRX 8-K 📊 Moleculin Biotech regains Nasdaq compliance delisting hearing cancelled From the filing: [--] active clinical trials Pipeline: [--] active trials 🟢 Data Assessment: POSITIVE Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1659617/000143774926000695 http://sec.gov/Archives/edgar/data/1659617/000143774926000695"  
[X Link](https://x.com/booooogy01/status/2008898163072233571)  2026-01-07T13:47Z [--] followers, [--] engagements


"$PDSB 8-K 📊 PDS Biotechnology submits amended Phase [--] protocol to FDA for PDS0101 in HPV16+ head and neck cancer aligning on PFS as primary endpoint. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1472091/000114036126000786 http://sec.gov/Archives/edgar/data/1472091/000114036126000786"  
[X Link](https://x.com/booooogy01/status/2009670346669207871)  2026-01-09T16:55Z [--] followers, [---] engagements


"$PRLD Prelude Therapeutics 8-K Prelude Therapeutics provides pipeline updates: JAK2V617F inhibitor Phase [--] planned for 2Q [----] KAT6A degrader IND. 📊 NEUTRAL: Trial results shape development path and investor confidence 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1678660/000119312526008280 https://twitter.com/i/web/status/2009677804506624211 http://sec.gov/Archives/edgar/data/1678660/000119312526008280 http://sec.gov/Archives/edgar/data/1678660/000119312526008280 https://twitter.com/i/web/status/2009677804506624211"  
[X Link](https://x.com/booooogy01/status/2009677804506624211)  2026-01-09T17:25Z [--] followers, [---] engagements


"$ALNY 8-K 📊 Alnylam reports $2.987B [----] net product revenues guides $4.9B-$5.3B for [----]. [--] active PHASE3 trials 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1178670/000162828026001755 http://sec.gov/Archives/edgar/data/1178670/000162828026001755"  
[X Link](https://x.com/booooogy01/status/2010691496492634307)  2026-01-12T12:33Z [--] followers, [---] engagements


"$MBRX 8-K 📊 Moleculin Biotech announces no cardiotoxicity in Annamycin study and initiates Phase [--] trial From the filing: [--] active clinical trial 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1659617/000143774926001140 http://sec.gov/Archives/edgar/data/1659617/000143774926001140"  
[X Link](https://x.com/booooogy01/status/2011075287879204902)  2026-01-13T13:58Z [--] followers, [--] engagements


"$CLNN 8-K 📊 Clene Inc. raises $6.0 million via securities purchase agreement subject to material conditions. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1822791/000143774926001196 http://sec.gov/Archives/edgar/data/1822791/000143774926001196"  
[X Link](https://x.com/booooogy01/status/2011192026302210484)  2026-01-13T21:41Z [--] followers, [--] engagements


"$EBS Emergent BioSolutions 8-K Emergent BioSolutions (EBS) Announces FDA Approval for New NARCAN Carrying Case $100M Debt Paydown and $50M Share. 🟢 BULLISH: SEC disclosure provides transparency on material events 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1367644/000119312526013061 http://sec.gov/Archives/edgar/data/1367644/000119312526013061"  
[X Link](https://x.com/booooogy01/status/2011564051390685483)  2026-01-14T22:20Z [--] followers, [--] engagements


"$HOTH 8-K 📊 Hoth Therapeutics reports positive HT-001 case study data and ongoing Phase 2a trial with HT-KIT preclinical results. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1711786/000121390026004899 http://sec.gov/Archives/edgar/data/1711786/000121390026004899"  
[X Link](https://x.com/booooogy01/status/2012157328024629261)  2026-01-16T13:37Z [--] followers, [--] engagements


"$PHIO - Phase 1b data for PH-762 is out 70% response rate in cSCC safety looks good. They've got [--] active trials ongoing mostly in phase [--]. Next up is extended safety follow-up data in Q2"  
[X Link](https://x.com/booooogy01/status/2013622078059225340)  2026-01-20T14:38Z [--] followers, [---] engagements


"$ATXS - Astria Therapeutics stockholders approve acquisition by BioCryst Pharmaceuticals expected to close January [--] [----] Standard filing"  
[X Link](https://x.com/booooogy01/status/2014084780300943404)  2026-01-21T21:16Z [--] followers, [--] engagements


"$IXHL - Forms clinical advisory board for PSX-001 Nasdaq delisting risk still looming stock down 6.56% today. Tough space with $AMPH and $MNMD competing"  
[X Link](https://x.com/booooogy01/status/2014316324529311840)  2026-01-22T12:36Z [--] followers, [---] engagements


"$INDV - Redomiciled to US new parent co formed [--] active Phase [--] trials for F. Now waiting on SEC reporting requirements"  
[X Link](https://x.com/booooogy01/status/2015758425561407862)  2026-01-26T12:07Z [--] followers, [--] engagements


"$FOLD - Acquisition still pending Preliminary [----] revenue at $634M waiting on that SEC proxy statement now"  
[X Link](https://x.com/booooogy01/status/2015776210052411442)  2026-01-26T13:17Z [--] followers, [--] engagements


"$MIST - CARDAMYST hits US shelves [--] active Phase [--] trials ongoing. Next up promotional launch mid-February. Stock's down 3% today though"  
[X Link](https://x.com/booooogy01/status/2015795097816989734)  2026-01-26T14:32Z [--] followers, [---] engagements


"$MIRM - Acquired Bluejay Therapeutics [--] active Phase [--] trials ongoing just raised $268.5M to push brelovitug in HDV. Topping $270M cash position sets them up for 2H '26 catalysts"  
[X Link](https://x.com/booooogy01/status/2015895781950345559)  2026-01-26T21:13Z [--] followers, [--] engagements


"$CALC - KOURAGE trial halted due to safety concerns. AP and PAH programs still on track pending FDA feedback. Stock's down 8.57% today next catalyst is pivotal trial design in AP by mid-year"  
[X Link](https://x.com/booooogy01/status/2016484228465144058)  2026-01-28T12:11Z [--] followers, [---] engagements


"$ADTX - Got Nasdaq extension to May [--] Need to regain compliance but it's contingent on financing and reporting. Stock's down 18% today pressure's on"  
[X Link](https://x.com/booooogy01/status/2016498057114751349)  2026-01-28T13:06Z [--] followers, [--] engagements


"$RGNX - REGENXBIO Inc. (RGNX) faces FDA clinical holds on RGX-111 and RGX-121 due to neoplasm case Rough patch"  
[X Link](https://x.com/booooogy01/status/2016505685542924605)  2026-01-28T13:36Z [--] followers, [---] engagements


"$ANVS - Phase 2/3 Alzheimer's data dropped Buntanetap showed significant cognitive improvement in mild cases. Now we wait for pivotal Phase [--] recruitment to wrap up this spring"  
[X Link](https://x.com/booooogy01/status/2016625503311188206)  2026-01-28T21:32Z [--] followers, [---] engagements


"$ENVB - Raised $1.5M in registered direct offering Tough day with a 16% drop but they got the cash. $ATAIB and $IXHL are still in the mix so we'll see how this plays out"  
[X Link](https://x.com/booooogy01/status/2016634210791149917)  2026-01-28T22:07Z [--] followers, [---] engagements


"$RPTX - Acquired by XenoTherapeutics for $2.20/share. Delisting from Nasdaq now. That's a wrap SEC deregistration next"  
[X Link](https://x.com/booooogy01/status/2016634577578840149)  2026-01-28T22:08Z [--] followers, [---] engagements


"$IXHL - Boosts Clinical Advisory Board Added [--] experts to guide PSX-001 Phase [--] for anxiety a crowded space with $AMPH and $AXSM. Stock's down 12% today though"  
[X Link](https://x.com/booooogy01/status/2016860626161647991)  2026-01-29T13:06Z [--] followers, [---] engagements


"$SCPX - Lost all non-cash assets in foreclosure. Wiped out stock down 100% today. Not much left here"  
[X Link](https://x.com/booooogy01/status/2016985584112455952)  2026-01-29T21:23Z [--] followers, [--] engagements


"$DARE - Raised $25.45K in Reg A offering Could raise up to $24.27M more. They've got [--] active Phase [--] trial ongoing. Cash will help but next catalyst isn't till 2027"  
[X Link](https://x.com/booooogy01/status/2016996568843636899)  2026-01-29T22:07Z [--] followers, [--] engagements


"$MIRA - Started final cohort dosing for Ketamir-2 [--] active trials ongoing mostly in Phase [--]. Next step is Phase 2a for CIPN pending FDA feedback. Stock's down 9.7% today"  
[X Link](https://x.com/booooogy01/status/2018431030181741030)  2026-02-02T21:07Z [--] followers, [--] engagements


"SEC Filing: https://www.sec.gov/Archives/edgar/data/1904286/000149315226004739 https://www.sec.gov/Archives/edgar/data/1904286/000149315226004739"  
[X Link](https://x.com/booooogy01/status/2018431033713328465)  2026-02-02T21:07Z [--] followers, [--] engagements


"$ICCC - ImmuCell Corporation enters new executive employment agreements and grants performance-based stock options contingent on shareholder approval FYI"  
[X Link](https://x.com/booooogy01/status/2018450955700752472)  2026-02-02T22:26Z [--] followers, [---] engagements


"$PFE - FDA nods Padcev combo [--] active Phase [--] trials ongoing. $7B Metsera deal adds to pipeline. Stock up 3% today VESPER-3 results due June 6"  
[X Link](https://x.com/booooogy01/status/2018657475101331600)  2026-02-03T12:07Z [--] followers, [---] engagements


"$APLT - acquired by Cycle Group for $14.3M going private. Delisting from Nasdaq repayment due soon"  
[X Link](https://x.com/booooogy01/status/2018688834826084817)  2026-02-03T14:11Z [--] followers, [---] engagements


"$ABBV - FDA nods Epkinly for follicular lymphoma [--] active Phase [--] trials ongoing. $61B in '25 revenue sets a high bar for '26 outlook"  
[X Link](https://x.com/booooogy01/status/2019032642814124440)  2026-02-04T12:57Z [--] followers, [--] engagements


"$ENTXW - Expands OPKO Health partnership Oral LA-PTH and OXM programs get a boost. IND filing expected by year-end will be a big catalyst"  
[X Link](https://x.com/booooogy01/status/2019035538473484293)  2026-02-04T13:09Z [--] followers, [--] engagements


"$BMY - FDA nods for Breyanzi in MZL Breyanzi just got approved for marginal zone lymphoma and they dropped positive Phase [--] data for Camzyos. Stock's up 5.5% today next big date is Opdivo's PDUFA goal on April 8"  
[X Link](https://x.com/booooogy01/status/2019383674685288889)  2026-02-05T12:12Z [--] followers, [--] engagements


"📋📊 $FTLF FitLife Brands Inc. Utilizes New Corporate Presentation On December [--] [----] FitLife Brands Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998740477470769614)  2025-12-10T13:03Z [--] followers, [--] engagements


"🟢🔥 $TNYA Tenaya Therapeutics Reports Positive Interim Data from RIDGE-1 Phase 1b/2 Trial of TN-401 On December [--] [----] Tenaya Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999226075524792428)  2025-12-11T21:13Z [--] followers, [---] engagements


"$PTIX 8-K 🔴 Protagenic Therapeutics receives Nasdaq delisting notice From the filing: Reason not specified Pipeline: No active trials data available 🔴 Data Assessment: NEGATIVE 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1022899/000149315226000263 http://sec.gov/Archives/edgar/data/1022899/000149315226000263"  
[X Link](https://x.com/booooogy01/status/2008159629205987547)  2026-01-05T12:52Z [--] followers, [---] engagements


"$SPRB SPRUCE BIOSCIENCES 8-K Spruce Biosciences secures up to $50M loan from Avenue Capital with $15M initial tranche extending cash runway into. 📊 NEUTRAL: Capital raise extends runway and funds development programs 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1683553/000119312526007038 http://sec.gov/Archives/edgar/data/1683553/000119312526007038"  
[X Link](https://x.com/booooogy01/status/2009272334843302234)  2026-01-08T14:33Z [--] followers, [---] engagements


"$ANNX 8-K 📊 Annexon files MAA for tanruprubart in GBS with EMA. Reports completed Phase [--] data for vonaprument in GA showing vision protection. 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1528115/000119312526009740 http://sec.gov/Archives/edgar/data/1528115/000119312526009740"  
[X Link](https://x.com/booooogy01/status/2010686511851639066)  2026-01-12T12:13Z [--] followers, [--] engagements


"$BCYC 8-K 📊 Bicycle Therapeutics PLC reports promising Phase [--] data and initiates new trials with regulatory feedback expected in [----] 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1761612/000110465926002706 http://sec.gov/Archives/edgar/data/1761612/000110465926002706"  
[X Link](https://x.com/booooogy01/status/2010687464222982332)  2026-01-12T12:17Z [--] followers, [--] engagements


"$LXEO Lexeo Therapeutics 8-K Lexeo Therapeutics Inc. (LXEO) receives FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia. 📊 NEUTRAL: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1907108/000119312526010091 http://sec.gov/Archives/edgar/data/1907108/000119312526010091"  
[X Link](https://x.com/booooogy01/status/2010756910077841425)  2026-01-12T16:53Z [--] followers, [---] engagements


"$PTCT 8-K 📊 PTC Therapeutics reports FDA and EMA approval of Sephience for PKU. From the filing: [----] revenue: $823M 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1070081/000110465926002799 http://sec.gov/Archives/edgar/data/1070081/000110465926002799"  
[X Link](https://x.com/booooogy01/status/2010759590519193854)  2026-01-12T17:03Z [--] followers, [---] engagements


"$ANNX 8-K 📊 Annexon presents Phase [--] vonaprument data (73% vision loss risk reduction) and Phase [--] tanruprubart results (90% response) 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1528115/000119312526012918 http://sec.gov/Archives/edgar/data/1528115/000119312526012918"  
[X Link](https://x.com/booooogy01/status/2011547900682047683)  2026-01-14T21:16Z [--] followers, [--] engagements


"$BCAB - Nasdaq delisting review underway Down 21.71% today going concern warning in the filing. Clock's ticking next catalyst is the delisting decision"  
[X Link](https://x.com/booooogy01/status/2020816610693693645)  2026-02-09T11:06Z [--] followers, [--] engagements


"$ABP - Nasdaq deficiency notice issued Got dinged for board independence and committee issues. Stock's already down 31.72% today. Not a great combo"  
[X Link](https://x.com/booooogy01/status/2021696317685477695)  2026-02-11T21:22Z [--] followers, [---] engagements


"$PLX - CHMP gives Elfabrio E4W dosing thumbs up Pending EC decision [--] active Phase [--] trials ongoing. Next catalyst is EC verdict by March 31"  
[X Link](https://x.com/booooogy01/status/2021714381197988227)  2026-02-11T22:34Z [--] followers, [--] engagements


"$ERNA - Priced $10.5M public offering Got $14.3M more potential from warrants but stock's down 64% today. Not a great day to raise cash"  
[X Link](https://x.com/booooogy01/status/2021714765085897043)  2026-02-11T22:35Z [--] followers, [--] engagements


"$LNAI - Nasdaq delisting notice filed Company's appealing but that's an uphill battle. Stock's up 26% today weirdly"  
[X Link](https://x.com/booooogy01/status/2022059112234979676)  2026-02-12T21:23Z [--] followers, [--] engagements


"$ANEB - Delisting from Nasdaq announced [--] active clinical trials still ongoing but stock's getting crushed down 42% today. Form [--] filing expected next week"  
[X Link](https://x.com/booooogy01/status/2022059582949143037)  2026-02-12T21:25Z [--] followers, [--] engagements


"Today in pharma 8-Ks: $MURA acquired by $XOMA. Delisted today. $CARM leaving Nasdaq voluntarily. OTC bound. $BIIB/$STOK - Dravet data positive. Seizures + cognition both improved. $INTS - [---] days to fix price or delist. $URGN - Hiring [--]. Commercial expansion"  
[X Link](https://x.com/booooogy01/status/1997029335367073985)  2025-12-05T19:44Z [--] followers, [---] engagements


"📋 $IPSC Century Therapeutics Appoints Dr. Han Lee and Dr. Martin Murphy to Board of Directors On December [--] [----] Century Therapeutics Inc. appointed Dr. Han Lee and Dr. Martin Murphy to its Board of Directors. The company is advancing CNTY-813 an investigational treatme #"  
[X Link](https://x.com/booooogy01/status/1998424243411767409)  2025-12-09T16:07Z [--] followers, [---] engagements


"🔴🔥 $MRUS Merus N.V. Approves Acquisition by Genmab A/S and Appoints New Directors On December [--] [----] Merus N. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998498630995755171)  2025-12-09T21:02Z [--] followers, [--] engagements


"🔴🔥 $GPCR Structure Therapeutics Inc. Completes $650 Million Follow-On Public Offering On December [--] [----] Structure Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1998877484922843293)  2025-12-10T22:08Z [--] followers, [--] engagements


"📋📊 $SRPT Sarepta Therapeutics Announces Refinancing of $291.4 Million in Convertible Notes On December [--] [----] Sarepta Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999090589980070191)  2025-12-11T12:15Z [--] followers, [---] engagements


"🔴🔥 $ALNY Alnylam Pharmaceuticals Inc. repurchases $34.4 million in convertible notes for $51.9 million On December [--] [----] Alnylam Pharmaceuticals Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999093380953821455)  2025-12-11T12:26Z [--] followers, [---] engagements


"🟢🔥 $CNTA Centessa Pharmaceuticals plc Appoints Mario Alberto Accardi PhD as CEO Effective January [--] [----] Centessa Pharmaceuticals plc has appointed Mario Alberto Accardi PhD as CEO effective January [--] [----] succeeding Saurabh Saha MD PhD. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999100176146022682)  2025-12-11T12:53Z [--] followers, [---] engagements


"🔴🔥 $CLYM Climb Bio Inc. Enters into Exchange Agreement for [--------] Shares On December [--] [----] Climb Bio Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999106548245975546)  2025-12-11T13:18Z [--] followers, [---] engagements


"🟢🔥 $CVKD Cadrenal Therapeutics Acquires VLX-1005 for $200000 and Receives FDA Orphan Drug Designation On December [--] [----] Cadrenal Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999106695361175625)  2025-12-11T13:19Z [--] followers, [--] engagements


"📋📊 $ORKA Oruka Therapeutics Inc. appoints Christopher Martin as Class II director and grants stock options On December [--] [----] Oruka Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999225795764715909)  2025-12-11T21:12Z [--] followers, [--] engagements


"📋🔥 $MRUS Merus N.V. Completes Acquisition by Genmab A/S for $6.9 Billion On December [--] [----] Merus N. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999521048182825189)  2025-12-12T16:45Z [--] followers, [--] engagements


"🟢🔥 $IPSC Century Therapeutics Inc. reports CNTY-101 Phase 1/2 results showing deep B-cell depletion in autoimmune disease patients Century Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999587743098388549)  2025-12-12T21:10Z [--] followers, [---] engagements


"📋📊 $ABT Abbott Laboratories Announces Amendments to Bylaws and Leadership Changes #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999588192866172984)  2025-12-12T21:12Z [--] followers, [---] engagements


"📋📊 $TNYA Tenaya Therapeutics announces pricing of public offering for $60 million Tenaya Therapeutics Inc. #SEC #8K #Pharma #Biotech"  
[X Link](https://x.com/booooogy01/status/1999593245979070817)  2025-12-12T21:32Z [--] followers, [---] engagements


"🧬 M&A + balance-sheet chess: 🤝 Genmab buys Merus at $97/share cash; 94.2% tendered closing underway 📉 ALNY repurchases $34.4M converts for $51.9M cash; $362.8M remain Money is moving FAST. #MNA http://sec.gov http://sec.gov"  
[X Link](https://x.com/booooogy01/status/1999897766554988899)  2025-12-13T17:42Z [--] followers, [---] engagements


"$IMNM Immunome 8-K Immunome Inc. Reports Positive Phase [--] Data for Varegacestat in Desmoid Tumors 🟢 BULLISH: Regulatory filing starts review clock for potential approval 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1472012/000119312525318429 http://sec.gov/Archives/edgar/data/1472012/000119312525318429"  
[X Link](https://x.com/booooogy01/status/2000539141491314775)  2025-12-15T12:11Z [--] followers, [---] engagements


"$KTTA Pasithea Therapeutics New 8-K filing #Pharma #8K"  
[X Link](https://x.com/booooogy01/status/2000553021772861495)  2025-12-15T13:06Z [--] followers, [--] engagements


"$CLYM 8-K 📊 Climb Bio engaged in litigation with Alumis Inc. over royalty obligations for Budoprutug. From the filing: Disputed royalty obligations Pipeline: No trial data available 📊 Data Assessment: NEUTRAL 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1768446/000119312525338318 http://sec.gov/Archives/edgar/data/1768446/000119312525338318"  
[X Link](https://x.com/booooogy01/status/2006475070886261176)  2025-12-31T21:18Z [--] followers, [--] engagements


"$NMRA 8-K 📊 Neumora Therapeutics updates clinical pipeline with NMRA-511 data. From the filing: NMRA-511 shows positive results Pipeline: Data not specified 📊 Data Assessment: NEUTRAL 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1885522/000119312526001472 http://sec.gov/Archives/edgar/data/1885522/000119312526001472"  
[X Link](https://x.com/booooogy01/status/2008143023863980508)  2026-01-05T11:46Z [--] followers, [--] engagements


"$PLX 8-K 📊 Protalix BioTherapeutics submits IND for PRX-115 and announces partnerships for Elfabrio and Elelyso 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1006281/000110465926000393 http://sec.gov/Archives/edgar/data/1006281/000110465926000393"  
[X Link](https://x.com/booooogy01/status/2008146899052663048)  2026-01-05T12:01Z [--] followers, [--] engagements


"$JBIO 8-K 📊 Jade Biosciences advances pipeline with $336M cash position From the filing: Cash position: $336M 📊 Data Assessment: NEUTRAL Thoughts 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1798749/000119312526001502 http://sec.gov/Archives/edgar/data/1798749/000119312526001502"  
[X Link](https://x.com/booooogy01/status/2008152013981249625)  2026-01-05T12:22Z [--] followers, [--] engagements


"$GPCR 8-K 📊 Structure Therapeutics enters $100M licensing agreement with Genentech and Roche for oral GLP-1 receptor agonists 🟢 Data Assessment: POSITIVE 🔗 #SEC #8K #Pharma #Biotech http://sec.gov/Archives/edgar/data/1888886/000110465926000620 http://sec.gov/Archives/edgar/data/1888886/000110465926000620"  
[X Link](https://x.com/booooogy01/status/2008285845196100051)  2026-01-05T21:13Z [--] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing